MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage LIB-ILIB NSCLC.

Details

Language :

English

ISSN :

15257304

Volume :

25

Issue :

6

Database :

Complementary Index

Journal :

Clinical Lung Cancer

Publication Type :

Academic Journal

Accession number :

180691149

Full Text :

https://doi.org/10.1016/j.cllc.2024.06.007